Titan Medical Inc. Appoints Dr. Balasubramanian Sivakumar to Its Medical Advisory Board
TORONTO, ONTARIO -- (MARKET WIRE) -- 08/18/11 -- Titan Medical Inc. ("the Company") (TSX VENTURE: TMD) announced today that it has appointed Dr. Balasubramanian Sivakumar, M.D., to the Company's Medical Advisory Board.
"We are very pleased to have Dr. Sivakumar join our team," said Dr. Reiza Rayman, President of Titan Medical Inc. "Dr. Sivakumar has been recognized by his peers as one of the very best general surgeons in his community, and his 33 years of experience will be invaluable in the execution of our general surgery strategic initiatives and milestones for the Amadeus Composer."
"I am very excited about the opportunity to be a Medical Advisor to Titan Medical," said Dr. Sivakumar. "Robotic surgery is here to stay and it is my hope that my experience, knowledge and guidance will advance robotics in my specialty of general surgery."
Dr. Sivakumar is currently Vice President of St. Joseph's Hospital Health Center in Syracuse, NY and President elect of the medical staff for 2012. During his medical career, Dr. Sivakumar has achieved numerous awards such as The Patricia Ann Award of Excellence at St. Joseph's Hospital Health Center which signifies the most distinguished award to a physician of the Highest Quality (1990); The CNY magazine 2010 Peer Recognition Award as the Best General Surgeon in the Region; and the Physician Top Star Award from St. Joseph's Hospital in 2009, to name just a few. Dr. Sivakumar is a robotic surgery proctor/mentor and has trained numerous surgeons practicing robotic surgery in specialties including General Surgery; Cardiac Surgery; Urologic Surgery; Thoracic Surgery, and Gynecologic Surgery. Dr. Sivakumar is currently Clinical Assistant Professor at SUNY Health Science Center in Syracuse, NY and Director for Advanced Cardiac Life Support program at St. Joseph's Hospital Health Center. In addition, he teaches family practice residents at St. Joseph's Health Center. Dr. Sivakumar's administrative responsibilities include Director of the Surgical Critical Care Unit; Surgeon, Ambulatory Care Unit; and Director of the Department of Surgical Physician Assistants at St. Joseph's Hospital Health Center.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company (TSX VENTURE: TMD) focused on the development and commercialization of robotic surgical technologies. The Company is currently developing Amadeus Composer™, a surgical system that has a uniquely designed external robot and flexible instruments, and allows surgeons to overcome constraints of surgical procedures in small to medium spaces. Amadeus Maestro™, the Company's next generation 4-armed robotic surgical system with advanced communication and training, utilizes the Titan True Touch Technology and is targeted to surgical procedures in large spaces. Robotic surgery has developed over the past 10 years into a proven and growing method of treatment. The global robotic surgical market size is currently estimated to be approximately $1 billion and is estimated to grow to $5 billion by 2015 with potential for placement of 6,000 robotic surgical systems. The Company is researching and developing innovative technologies to empower surgeons to use robots in the operating room of the future. For more information, visit the Company's website at www.titanmedicalinc.com.
Forward Looking Statements
This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors" section of the Company's Annual Information Form dated March 31, 2011 (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts: Titan Medical Inc. Craig Leon Chief Executive Officer (416) 548-7522 (ext. 151) cleon@titanmedicalinc.com www.titanmedicalinc.com ICR, LLC Sherry Bertner Managing Director (646) 277-1247 Sherry.Bertner@icrinc.com
Source: Titan Medical Inc.
Released August 18, 2011